Not long after the CE-marking certificates were received, the first cartons of Moyos were sent off to Tanzania.
To make sure that the midwives were comfortable using the Moyo, selected midwives from Temeke, Muhimbili and Haydom were taken through a training of trainers course using the Moyo training package. Since then provider training have been conducted and Moyo have been introduced in the clinic.
During a recent visit to Haydom, some of the LGH engineers took these wonderful pictures from the Moyo being in use in the clinic. .
Photo: Midwife using the Moyo for a check up of a mother before admission.
Photo: Moyo being used in the second stage of labor.
Photo: The midwives are very happy with their new tool, allowing them to monitor fetal heart rate in a more effectively and insuring mobility of the mother when monitored.
On the 27th of March, Laerdal Global Health submitted an application for funding to the prestigious Saving Lives at Birth Grand Challange. The project proposed is expanding the field-testing of our new innovative fetal heart rate monitor MOYO in two referral hospital and antenatal services in Tanzania.
Laerdal Global Health’s low-cost Fetal Heart Rate (FHR) monitor; MOYO and it’s training program will help providers measure FHR faster, automatically and more accurate to make timely obstetric responses when detecting fetuses at risk. This will reduce the burden of stillbirths and births asphyxia, estimated to account for 2million perinatal deaths annually. 98-99% of these deaths occur in low and middle-income countries. Expanding the use of MOYO to referring hospitals and dispensaries will help detecting fetuses at risk earlier and improve referrals. Training antenatal care providers and using MOYO at antenatal visits, will improve the antenatal follow-up, build trust with providers and help encourage mothers to deliver in a safe environment.
Inspirational. That’s how I would sum up my experience at Haydom with only one word. Seeing the dedication of the hospital staff on saving lives at Haydom Lutheran Hospital was truly a rewarding experience.
The journey from Stavanger to Haydom was long, using almost every means of transportation from jumbo jets and cars to small planes with an only 6-men-capacity including the pilot. This was not a leisure trip, we did this journey to bring and install a few Laerdal Newborn Resuscitation Monitors to the hospital, so we had a quite important task. Upon our arrival, we were greeted with such joy and enthusiasm, and it was clear that they had been anticipating the first fruits of this project.
To not lose any time, we started working immediately since we wanted to get the best out of our three day stay at Haydom. From day one, everything went really smooth until our departure. Quite the rare thing in Tanzania, I was told. I took that as a good sign. While installing the Newborn Resuscitation Monitors in the labor rooms, we were simultaneously giving training to two bright research nurses on the purpose and use of the monitors. These research nurses in turn successfully trained the rest of the maternity staff. Everyone was very curious to see if the monitor would provide what was promised a year ago. Shortly, the curiosity turned into confidence and it was very rewarding to see the product being used in the actual setting.
Despite my short stay, I had the wonderful opportunity to get to know Fortunata and Editha, two of the midwives. Becoming friends and earning their trust felt just as important as understanding their professional needs and desires. Experiencing the environment first-hand made me truly understand the challenges the staff at Haydom face every day. Seeing the products being used in context and understanding the daily work-flow provided invaluable knowledge on what is really needed in different situations. Kind of knowledge which is impossible to grasp without being in the field. I could truly see how Laerdal’s products came to use where it is needed the most. There are still many lives to save and we have a huge responsibility to provide products relevant for the need.
Despite the difficult reality of battling the high mortality rate of the newborns in Haydom, I feel very inspired after seeing their tremendous efforts, true dedication on saving lives, and their ability to always share a smile. There are miracles happening every day at Haydom and I am really excited about the possibilities ahead. I am sending my deepest greetings to the wonderful people that I encountered during my stay at Haydom.
Cenk Aytekin, Industrial Designer at Laerdal Medical
On the March 1st 2013 the randomized controlled trial with the aim to determine the most efficient way to monitor fetal heart rate, using fetoscope vs. wind-up handheld Doppler was started in Muhimbili National Hospital in Dar es Salaam and Haydom Lutheran Hospital in Manyara Region, Tanzania.
Today, in most low-income countries, the Pinard fetoscope is used by midwifes to monitor fetal heart rate. However, the technique is not easy and it is difficult to take measurements as frequently as recommended. In most labor wards in low-income countries there are few midwives and many deliveries. Intermittent fetal heart rate measurement by fetoscope every 15min as per guidelines is therefore not feasible.
Recent research at Haydom shows however that intermittent detection of an absent or abnormal fetal heart rate using a fetoscope is associated with fresh still birth, increased neonatal resuscitation, birth asphyxia and neonatal death in a resource limited setting. The likelihood of an abnormal fetal heart rate is magnified with labor complications.
Hence, the ability to detect the fetus at risk during and immediately after labor is key and a critical catalyst for timely interventions to reduce deaths and morbidity. In western countries continuous electronic fetal heart rate monitoring is the “gold standard”. About two decades ago research concluded that Doppler ultrasound monitoring should be promoted in low resources countries where electronic monitoring is not feasible. However, there has been no advancement in fetal heart rate monitoring since then.
Laerdal Global Health in cooperation with Laerdal Medical AS is now in the process of developing the Laerdal Fetal Heart Rate Monitor. In the second phase of the randomized controlled trial, this monitor will be tested against the best device from the first phase. Using innovative ultrasound technology the Laerdal Fetal Heart Rate Monitor will consist of one probe including several Doppler transducers ensuring easier fetal heart rate detection. Software will be developed for automatic intermittent assessments.